Trials / Completed
CompletedNCT03191734
French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- PROCEPT BioRobotics · Industry
- Sex
- Male
- Age
- 45 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Single arm, multi-center prospective clinical trial to determine the safety and effectiveness of the AQUABEAM System in the treatment of benign prostatic hyperplasia (BPH) in men 45 to 80 years of age.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AQUABEAM System | Aquablation is a minimally invasive transurethral surgical procedure using the AQUABEAM system, a personalized image-guided waterject resection system that utilizes a high-pressure saline stream to resect and remove prostate tissue. |
Timeline
- Start date
- 2017-09-19
- Primary completion
- 2018-07-02
- Completion
- 2019-01-07
- First posted
- 2017-06-19
- Last updated
- 2019-02-22
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03191734. Inclusion in this directory is not an endorsement.